MA28427B1 - Reactions de couplage utilisees pour la preparation de derives (1h-tetrazol-5-yl)-biphenyl - Google Patents
Reactions de couplage utilisees pour la preparation de derives (1h-tetrazol-5-yl)-biphenylInfo
- Publication number
- MA28427B1 MA28427B1 MA29224A MA29224A MA28427B1 MA 28427 B1 MA28427 B1 MA 28427B1 MA 29224 A MA29224 A MA 29224A MA 29224 A MA29224 A MA 29224A MA 28427 B1 MA28427 B1 MA 28427B1
- Authority
- MA
- Morocco
- Prior art keywords
- tetrazol
- preparation
- coupling reactions
- reactions used
- biphenyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
La présente invention concerne un procédé permettant de fabriquer des produits intermédiaires qui peuvent être utilisés pour la fabrication de ARB (également appelés antagonistes des récepteurs de l'angiotensine II ou antagonistes des récepteurs AT1) comprenant, en tant qu'élément structurel commun, un noyau (IH-tetrazol-5-yl)-biphényl.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0402262.0A GB0402262D0 (en) | 2004-02-02 | 2004-02-02 | Process for the manufacture of organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28427B1 true MA28427B1 (fr) | 2007-02-01 |
Family
ID=31985494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29224A MA28427B1 (fr) | 2004-02-02 | 2006-08-01 | Reactions de couplage utilisees pour la preparation de derives (1h-tetrazol-5-yl)-biphenyl |
Country Status (19)
Country | Link |
---|---|
US (2) | US7700784B2 (fr) |
EP (2) | EP1716140A1 (fr) |
JP (1) | JP2007519684A (fr) |
KR (1) | KR20060128993A (fr) |
CN (1) | CN100528868C (fr) |
AU (1) | AU2005211500B2 (fr) |
BR (1) | BRPI0507352A (fr) |
CA (1) | CA2553246A1 (fr) |
CO (1) | CO5700717A2 (fr) |
EC (1) | ECSP066727A (fr) |
GB (1) | GB0402262D0 (fr) |
IL (2) | IL176904A0 (fr) |
MA (1) | MA28427B1 (fr) |
NO (1) | NO20063920L (fr) |
NZ (1) | NZ548690A (fr) |
RU (2) | RU2426728C2 (fr) |
TN (1) | TNSN06238A1 (fr) |
WO (1) | WO2005075462A1 (fr) |
ZA (1) | ZA200605462B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0222056D0 (en) * | 2002-09-23 | 2002-10-30 | Novartis Ag | Process for the manufacture of organic compounds |
JP5023720B2 (ja) * | 2006-08-04 | 2012-09-12 | 東ソー株式会社 | ハロゲン化ビフェニル類の製造方法 |
EP2217205B1 (fr) * | 2007-11-06 | 2015-03-04 | Novartis AG | Compositions pharmaceutiques à double action basées sur superstructures de récepteur antagoniste de l'angiotensine/inhibiteur (arb) et l'endopeptidase neutre (NEP) inhibiteur |
PE20091364A1 (es) | 2008-01-17 | 2009-10-13 | Novartis Ag | Proceso para la preparacion de inhibidores de nep |
JP5203144B2 (ja) * | 2008-11-07 | 2013-06-05 | 東ソー株式会社 | スチレン類の製造方法 |
JP5261140B2 (ja) * | 2008-11-07 | 2013-08-14 | 東ソー株式会社 | ビニル芳香族化合物の製造方法 |
CA2806780A1 (fr) | 2010-08-23 | 2012-03-01 | Novartis Ag | Procede de preparation d'intermediaires pour produire des inhibiteurs de l'endopeptidase neutre (epn) |
PL2610248T3 (pl) * | 2010-08-27 | 2016-12-30 | Sposób wytwarzania podstawionych fenylem pochodnych heterocyklicznych metodą sprzęgania z użyciem związku palladu | |
CN103467341B (zh) * | 2013-08-29 | 2015-02-25 | 河南师范大学 | 一种沙坦联苯的制备方法 |
CN104987327A (zh) * | 2015-07-13 | 2015-10-21 | 朱绍清 | 一种四唑类衍生物的催化合成方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1334092C (fr) | 1986-07-11 | 1995-01-24 | David John Carini | Imidazoles bloquant les recepteurs de l'angiotensine ii |
US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
US4874867A (en) * | 1987-05-22 | 1989-10-17 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
EP0955294B1 (fr) | 1989-06-14 | 2003-09-24 | Smithkline Beecham Corporation | Acides imidazoalcénoiques |
EP0443983B1 (fr) | 1990-02-19 | 1996-02-28 | Ciba-Geigy Ag | Composés acylés |
GB9005354D0 (en) * | 1990-03-09 | 1990-05-02 | Glaxo Group Ltd | Chemical compounds |
NZ237476A (en) | 1990-03-20 | 1994-01-26 | Sanofi Sa | N-substituted heterocyclic compounds and pharmaceutical compositions. |
US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
IE920540A1 (en) | 1991-02-21 | 1992-08-26 | Sankyo Co | 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use |
TW226375B (fr) | 1991-10-24 | 1994-07-11 | American Home Prod | |
US5310928A (en) * | 1991-11-18 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Process for preparing biphenyltetrazole compounds |
US5206374A (en) * | 1991-11-18 | 1993-04-27 | E. I. Du Pont De Nemours And Company | Process for preparing tetrazolylphenylboronic acid intermediates |
FR2688503B1 (fr) | 1992-03-16 | 1994-05-06 | Synthelabo | Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle]. |
EP0550313A1 (fr) * | 1991-12-30 | 1993-07-07 | Synthelabo | Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse |
US5468867A (en) * | 1994-05-27 | 1995-11-21 | Syntex (U.S.A.) Inc. | Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid |
AU3868595A (en) | 1994-10-27 | 1996-05-23 | Novartis Ag | Process for the preparation of tetrazoles |
JP3763869B2 (ja) * | 1994-12-26 | 2006-04-05 | 東ソー・ファインケム株式会社 | ビフェニル化合物の製造方法 |
US5922898A (en) * | 1997-04-08 | 1999-07-13 | Catalytica Pharmaceuticals, Inc. | Process for preparing biaryl compounds |
DE10057679A1 (de) * | 2000-11-21 | 2002-05-29 | Forschungszentrum Juelich Gmbh | Brennstoffzellenstapel mit Kreislaufführung |
BR0313000A (pt) * | 2002-07-19 | 2005-07-12 | Memory Pharm Corp | Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente |
GB0222056D0 (en) * | 2002-09-23 | 2002-10-30 | Novartis Ag | Process for the manufacture of organic compounds |
PT1590343E (pt) * | 2003-02-05 | 2008-09-11 | Teva Pharma | Síntese de 2-butil-3-(2¿-(1-tritil-1h-tetrazol-5-il)bifenil-4-il)-1,3-diazaspiro-4,4-non-en-4-ona |
KR20060027801A (ko) | 2003-06-05 | 2006-03-28 | 제넨테크, 인크. | B 세포 장애에 대한 조합 요법 |
-
2004
- 2004-02-02 GB GBGB0402262.0A patent/GB0402262D0/en not_active Ceased
-
2005
- 2005-02-01 EP EP05707117A patent/EP1716140A1/fr not_active Withdrawn
- 2005-02-01 RU RU2006131460/04A patent/RU2426728C2/ru not_active IP Right Cessation
- 2005-02-01 CN CNB2005800037946A patent/CN100528868C/zh not_active Expired - Fee Related
- 2005-02-01 KR KR1020067015580A patent/KR20060128993A/ko not_active Application Discontinuation
- 2005-02-01 BR BRPI0507352-9A patent/BRPI0507352A/pt not_active IP Right Cessation
- 2005-02-01 CA CA002553246A patent/CA2553246A1/fr not_active Abandoned
- 2005-02-01 EP EP10164270A patent/EP2246348A1/fr not_active Withdrawn
- 2005-02-01 JP JP2006550140A patent/JP2007519684A/ja active Pending
- 2005-02-01 NZ NZ548690A patent/NZ548690A/xx unknown
- 2005-02-01 WO PCT/EP2005/000978 patent/WO2005075462A1/fr active Application Filing
- 2005-02-01 US US10/588,169 patent/US7700784B2/en not_active Expired - Fee Related
- 2005-02-01 AU AU2005211500A patent/AU2005211500B2/en not_active Ceased
-
2006
- 2006-07-03 ZA ZA200605462A patent/ZA200605462B/xx unknown
- 2006-07-17 IL IL176904A patent/IL176904A0/en unknown
- 2006-07-25 CO CO06072544A patent/CO5700717A2/es not_active Application Discontinuation
- 2006-07-26 EC EC2006006727A patent/ECSP066727A/es unknown
- 2006-07-31 TN TNP2006000238A patent/TNSN06238A1/en unknown
- 2006-08-01 MA MA29224A patent/MA28427B1/fr unknown
- 2006-09-01 NO NO20063920A patent/NO20063920L/no not_active Application Discontinuation
-
2010
- 2010-03-02 US US12/715,477 patent/US20100152458A1/en not_active Abandoned
- 2010-09-06 RU RU2010136996/04A patent/RU2010136996A/ru unknown
- 2010-10-03 IL IL208409A patent/IL208409A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1716140A1 (fr) | 2006-11-02 |
AU2005211500B2 (en) | 2009-04-02 |
RU2426728C2 (ru) | 2011-08-20 |
CN1914197A (zh) | 2007-02-14 |
GB0402262D0 (en) | 2004-03-10 |
RU2006131460A (ru) | 2008-03-10 |
KR20060128993A (ko) | 2006-12-14 |
BRPI0507352A (pt) | 2007-07-03 |
CO5700717A2 (es) | 2006-11-30 |
ZA200605462B (en) | 2009-06-24 |
US7700784B2 (en) | 2010-04-20 |
US20070129413A1 (en) | 2007-06-07 |
AU2005211500A1 (en) | 2005-08-18 |
US20100152458A1 (en) | 2010-06-17 |
NZ548690A (en) | 2009-08-28 |
CA2553246A1 (fr) | 2005-08-18 |
WO2005075462A1 (fr) | 2005-08-18 |
IL176904A0 (en) | 2006-12-10 |
TNSN06238A1 (en) | 2007-12-03 |
CN100528868C (zh) | 2009-08-19 |
NO20063920L (no) | 2006-10-30 |
EP2246348A1 (fr) | 2010-11-03 |
JP2007519684A (ja) | 2007-07-19 |
ECSP066727A (es) | 2006-10-31 |
IL208409A0 (en) | 2011-08-01 |
RU2010136996A (ru) | 2012-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28427B1 (fr) | Reactions de couplage utilisees pour la preparation de derives (1h-tetrazol-5-yl)-biphenyl | |
WO2006021213A3 (fr) | Antagonistes de récepteur v1a la vasopressine v1a | |
MA29915B1 (fr) | Benzimidazoles substitues utilises en tant qu'inhibiteurs de kinases | |
WO2006009734A8 (fr) | Antagonistes de récepteurs de l'hormone de libération de gonadotrophines | |
MX2010003325A (es) | Anticuepos novedosos. | |
MA29816B1 (fr) | Composes de benzimidazole thiophene | |
MA31910B1 (fr) | Antagonistes des recepteurs non steroidiens des mineralocorticoides derives de la 6h-dibenzo[b,e]oxepine | |
WO2008007211A8 (fr) | Composés de carboxyamide bicycliques à n-bicycloalkyle substitué | |
WO2008008517A3 (fr) | Diazépans pontés antagonistes du récepteur de l'oréxine | |
UA90706C2 (ru) | Антагонисты рецептора pgd2 для лечения воспалительных заболеваний | |
ATE463495T1 (de) | Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten | |
MY161834A (en) | Substituted diazepan compounds as orexin receptor antagonists | |
WO2008040774A3 (fr) | Antagoniste des rÉcepteurs de l'angiotensine II utilisÉ pour la prÉvention ou le traitement de maladies systÉmiques chez le chat | |
GB0510143D0 (en) | Novel compounds A1 | |
DE60214990D1 (de) | Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten | |
UA106873C2 (uk) | Сполуки заміщених діазепанів як антагоністи орексинових рецепторів | |
WO2006041830A3 (fr) | Antagonistes du recepteur de cgrp | |
WO2008059370A3 (fr) | Composés bicyclocarboxyamides substitués | |
CY1111227T1 (el) | Mεθοδος παρασκευης 1-υποκατασταθεισων ενωσεων 1η-ιμιδαζο[4,5-c]κινολιν-4-αμινης και ενδιαμεσα γι' αυτην. | |
WO2006044449A3 (fr) | Antagonistes des recepteurs du cgrp (peptide lie au gene de la calcitonine) | |
EP1398029A8 (fr) | Derivés de pyrazole,substitués en position 3 ayant une affinité envers le NR3B1 récepteur | |
WO2009086202A3 (fr) | Procédés de traitement d'affections neuropsychiatriques | |
WO2006054162A8 (fr) | Antagonistes azabicycliques des recepteurs muscariniques | |
MA28602B1 (fr) | Pyridin-4-yl-ethynyl-imidazoles et pyrazoles en tant qu'antagonistes des recepteurs mglur5 | |
WO2007052301A3 (fr) | Procede de preparation d'irbesartan |